Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive
1394.4000 7.70 (0.56%)
NSE Aug 17, 2026 15:31 PM
Volume: 155.5K
 

logo
Alivus Life Sciences Ltd.
29 Apr 2024
1394.40
0.56%
buy
by ICICI Direct
Target: 1040
ICICI Direct
 
Alivus Life Sciences has gained 33.49% in the last 3 Months
More from Alivus Life Sciences Ltd.
Recommended
IPO market heats up as Blackstone-backed Horizon leads a crowded mainboard calendar
| 17 Aug 2026, 05:50PM
Market closes lower as oil trades near $89 amid US-Iran deadlock
Trendlyne Marketwatch | 17 Aug 2026, 03:58PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021